Incannex Healthcare (IXHL) Cash & Equivalents (2020 - 2026)

Incannex Healthcare (IXHL) has reported Cash & Equivalents for 7 consecutive years, with $74.5 million the latest figure, recorded in Q1 2026.

• Quarterly Cash & Equivalents rose 1010.12% year-over-year to $74.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74.5 million (up 1010.12% YoY) and the FY2025 annual result came in at $15.0 million, up 154.9% from the prior year.
• Cash & Equivalents advanced to $74.5 million in Q1 2026 per IXHL's latest filing, from $68.9 million in the prior quarter.
• Over the last five years, Cash & Equivalents for IXHL reached as high as $74.5 million in Q1 2026 and fell as low as $2.1 million in Q4 2024.
• A 5-year average of $28.8 million and a median of $15.0 million in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents plunged 85.58% — and 2025, when it jumped 3184.08%.
• Year by year, Cash & Equivalents stood at $41.4 million in 2022, then plunged by 64.87% to $14.6 million in 2023, then tumbled by 85.58% to $2.1 million in 2024, then soared by 3184.08% to $68.9 million in 2025, then climbed by 8.13% to $74.5 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $74.5 million, $68.9 million, and $73.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.